Longitudinal changes in serum adropin levels and liver fat content during liraglutide treatment in newly diagnosed patients with type 2 diabetes mellitus and metabolic dysfunction-associated fatty liver disease.

Authors:
Zhang L; Wu X; Li X; Chang X; Ding X and 4 more

Journal:
Acta Diabetol

Publication Year: 2023

DOI:
10.1007/s00592-023-02082-3

PMCID:
PMC10198855

PMID:
37079136

Journal Information

Full Title: Acta Diabetol

Abbreviation: Acta Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare that they have no conflict of interest. Human rightsInformed written consent was received from all the participants prior to the study initiation. Approval was obtained from the ethics committee of Beijing Chao-yang Hospital, Capital Medical University. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Informed consentAll participants voluntarily signed written informed consent statements prior to study initiation. Conflict of interest The authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding This work was supported by grants from Beijing Natural Science Foundation Z20019 to J.L."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025